Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9125 |
High Similarity |
NPD3818 |
Discontinued |
0.891 |
High Similarity |
NPD2801 |
Approved |
0.8726 |
High Similarity |
NPD1934 |
Approved |
0.8679 |
High Similarity |
NPD3882 |
Suspended |
0.8623 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8606 |
High Similarity |
NPD7054 |
Approved |
0.8554 |
High Similarity |
NPD7074 |
Phase 3 |
0.8554 |
High Similarity |
NPD7472 |
Approved |
0.8533 |
High Similarity |
NPD1510 |
Phase 2 |
0.8526 |
High Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.8519 |
High Similarity |
NPD5494 |
Approved |
0.8509 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8452 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8438 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8393 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8385 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8344 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8303 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8267 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8263 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.825 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8221 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8204 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8165 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8158 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8148 |
Intermediate Similarity |
NPD37 |
Approved |
0.8141 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8101 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8026 |
Intermediate Similarity |
NPD943 |
Approved |
0.8013 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD919 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7953 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7952 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7939 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7937 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7879 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7879 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7879 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7857 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7824 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7811 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7809 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.774 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7738 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7736 |
Intermediate Similarity |
NPD2800 |
Approved |
0.773 |
Intermediate Similarity |
NPD920 |
Approved |
0.7722 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7719 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7628 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7628 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7625 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7619 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7607 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5403 |
Approved |
0.75 |
Intermediate Similarity |
NPD2344 |
Approved |
0.75 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7485 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7468 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7433 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7425 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7375 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7356 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7356 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7355 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7318 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7317 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7316 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7316 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7316 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7314 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7308 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7306 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7277 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7263 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7255 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7249 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7247 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7238 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7229 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7209 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7208 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7178 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7173 |
Intermediate Similarity |
NPD5006 |
Approved |
0.7173 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7173 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7166 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7135 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7126 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.712 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7117 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7115 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7113 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7107 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7092 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7078 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7076 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7056 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7055 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7053 |
Intermediate Similarity |
NPD4420 |
Approved |
0.7053 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7053 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7048 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD1470 |
Approved |
0.6994 |
Remote Similarity |
NPD6844 |
Discontinued |
0.6983 |
Remote Similarity |
NPD2403 |
Approved |
0.6982 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.697 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6935 |
Remote Similarity |
NPD8150 |
Discontinued |
0.6931 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6931 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6931 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD9545 |
Approved |
0.6928 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6927 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD9717 |
Approved |
0.6918 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6911 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD9493 |
Approved |
0.6902 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3268 |
Approved |
0.6882 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6867 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6862 |
Remote Similarity |
NPD4287 |
Approved |
0.6859 |
Remote Similarity |
NPD4361 |
Phase 2 |
0.6859
|
Remote Similarity |
NPD4362 |
Clinical (unspecified phase) |